Profile picture

Doctor Hiroaki Matsuda

Nagoya Heart Center, Nagoya (Japan)
Follow
Biography
EDUCATION and WORK EXPERIENCES Medical doctor working as an interventional cardiologist performed over 2000 PCI including challenging cases (CTO over 300 cases as a member of Japanese CTO interventional specialist ), becoming as chief of medical department and catheter laboratory from 2024. Medical school: April 2006 - March 2011 Shinshu University Clinical intership: April 2011 - March 2013 Kyushu Medical Center Resident doctor: April 2013 - March 2015 Kokura Memorial Hospital Medical doctor: April 2015 - March 2018 Otsu Red Cross Hospital April 2018 - Nagoya Heart Center
Logo ESC

Contributor content

A LMT bifurcation lesion newly emerged after emergent TAR
Presentation
A LMT bifurcation lesion newly emerged after emergent TAR
The acute procedural results and subsequent clinical outcomes after CTO-PCI: main-analysis of the japanese CTO-PCI expert registry
Presentation
The acute procedural results and subsequent clinical outcomes after CTO-PCI: main-analysis of the japanese CTO-PCI expert registry
Mid-term clinical outcomes of biodegradable polymer everolimus-eluting stents compared with durable polymer everolimus-eluting stents: a propensity-matched study
Presentation
Mid-term clinical outcomes of biodegradable polymer everolimus-eluting stents compared with durable polymer everolimus-eluting stents: a propensity-matched study
Biodegradable polymer everolimus-eluting stents versus durable polymer everolimus-eluting stents in diabetic patients : a 3-year propensity-matched study
Presentation
Biodegradable polymer everolimus-eluting stents versus durable polymer everolimus-eluting stents in diabetic patients : a 3-year propensity-matched study
Qualitative and quantitative comparison of the neointima between bare-metal stents and sirolimus-eluting stents in the very late phase (>7 years); analysis by optimal frequency domain imaging
Presentation
Qualitative and quantitative comparison of the neointima between bare-metal stents and sirolimus-eluting stents in the very late phase (>7 years); analysis by optimal frequency domain imaging

ESC 365 is supported by